Merit Medical Systems Inc
NASDAQ:MMSI

Watchlist Manager
Merit Medical Systems Inc Logo
Merit Medical Systems Inc
NASDAQ:MMSI
Watchlist
Price: 95.86 USD -0.17% Market Closed
Market Cap: 5.6B USD
Have any thoughts about
Merit Medical Systems Inc?
Write Note

Merit Medical Systems Inc
Depreciation & Amortization

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Merit Medical Systems Inc
Depreciation & Amortization Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Depreciation & Amortization CAGR 3Y CAGR 5Y CAGR 10Y
Merit Medical Systems Inc
NASDAQ:MMSI
Depreciation & Amortization
$97.7m
CAGR 3-Years
4%
CAGR 5-Years
2%
CAGR 10-Years
11%
Haemonetics Corp
NYSE:HAE
Depreciation & Amortization
$109.6m
CAGR 3-Years
6%
CAGR 5-Years
0%
CAGR 10-Years
3%
DENTSPLY SIRONA Inc
NASDAQ:XRAY
Depreciation & Amortization
$346m
CAGR 3-Years
0%
CAGR 5-Years
1%
CAGR 10-Years
10%
ICU Medical Inc
NASDAQ:ICUI
Depreciation & Amortization
$223.7m
CAGR 3-Years
36%
CAGR 5-Years
24%
CAGR 10-Years
28%
Align Technology Inc
NASDAQ:ALGN
Depreciation & Amortization
$139.9m
CAGR 3-Years
10%
CAGR 5-Years
14%
CAGR 10-Years
25%
Lantheus Holdings Inc
NASDAQ:LNTH
Depreciation & Amortization
$62.4m
CAGR 3-Years
17%
CAGR 5-Years
36%
CAGR 10-Years
13%
No Stocks Found

Merit Medical Systems Inc
Glance View

Economic Moat
None
Market Cap
5.6B USD
Industry
Health Care

Merit Medical Systems Inc. stands as a hallmark of innovation and precision in the medical device industry. Founded in 1987, this Utah-based company has carved a niche by developing and manufacturing a diverse range of products designed to enhance the ability of physicians and improve patient care. Merit's operations focus on the production of disposable medical devices catering primarily to the fields of interventional cardiology, radiology, endoscopy, and pain management. These products, which include a variety of catheters, microcatheters, embolization coils, and other technical components, are crucial in facilitating minimally invasive procedures that speak to the modern medical demand for efficiency and reduced patient recovery times. The company's relentless pursuit of quality and innovation has spurred consistent growth and expanded its presence globally, illustrating its commitment to meeting the evolving needs of healthcare providers and their patients. Revenue streams for Merit Medical Systems derive primarily from the sales of these specialized medical devices, accompanied by an expanding portfolio of customer-driven services and support. Unlike many companies that might get mired in a single product line, Merit has strategically diversified its offerings to spread risk and capture a broader segment of the healthcare market. This diversification is reflected in their investment in research and development, enabling the launch of new products regularly, thereby cushioning the company against the volatility typically seen in the medical device sector. The company’s success is a testament to its ability to maintain close relationships with healthcare providers, listening to and fulfilling their complex needs while operating through an intricate web of direct sales representatives and distribution partners globally. This cohesive model fosters both customer loyalty and drives sustainable business growth, ensuring that Merit Medical Systems remains a pivotal player in the evolving landscape of medical technology.

MMSI Intrinsic Value
89.48 USD
Overvaluation 7%
Intrinsic Value
Price

See Also

What is Merit Medical Systems Inc's Depreciation & Amortization?
Depreciation & Amortization
97.7m USD

Based on the financial report for Sep 30, 2024, Merit Medical Systems Inc's Depreciation & Amortization amounts to 97.7m USD.

What is Merit Medical Systems Inc's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 10Y
11%

Over the last year, the Depreciation & Amortization growth was 12%. The average annual Depreciation & Amortization growth rates for Merit Medical Systems Inc have been 4% over the past three years , 2% over the past five years , and 11% over the past ten years .

Back to Top